These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2674359

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells.
    Floridi A, Paggi MG, D'Atri S, De Martino C, Marcante ML, Silvestrini B, Caputo A.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4661-6. PubMed ID: 7306982
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of aerobic glycolysis in normal and neoplastic lymphoid cells induced by Lonidamine [1-(2,4-dichlorobenzyl)-I-H-indazol-3-carboxylic acid].
    Natali PG, Salsano F, Viora M, Nista A, Malorni W, Marolla A, De Martino C.
    Oncology; 1984 Nov; 41 Suppl 1():7-14. PubMed ID: 6609324
    [Abstract] [Full Text] [Related]

  • 8. Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure.
    Oudard S, Boitier E, Miccoli L, Rousset S, Dutrillaux B, Poupon MF.
    Anticancer Res; 1997 Nov; 17(3C):1903-11. PubMed ID: 9216643
    [Abstract] [Full Text] [Related]

  • 9. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy.
    Kalia VK, Prabhakara S, Narayanan V.
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S57-60. PubMed ID: 20009297
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification.
    Ben-Yoseph O, Lyons JC, Song CW, Ross BD.
    J Neurooncol; 1998 Jan; 36(2):149-57. PubMed ID: 9525814
    [Abstract] [Full Text] [Related]

  • 11. Effect of lonidamine on protein synthesis in neoplastic cells.
    Floridi A, Delpino A, Nista A, Feriozzi R, Marcante ML, Silvestrini B, Caputo A.
    Exp Mol Pathol; 1985 Jun; 42(3):293-305. PubMed ID: 3996552
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mitochondria-bound hexokinase as target for therapy of malignant gliomas.
    Oudard S, Poirson F, Miccoli L, Bourgeois Y, Vassault A, Poisson M, Magdelénat H, Dutrillaux B, Poupon MF.
    Int J Cancer; 1995 Jul 17; 62(2):216-22. PubMed ID: 7622299
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies.
    Ben-Horin H, Tassini M, Vivi A, Navon G, Kaplan O.
    Cancer Res; 1995 Jul 01; 55(13):2814-21. PubMed ID: 7796408
    [Abstract] [Full Text] [Related]

  • 15. Lonidamine in the combined treatment of malignant gliomas. A randomized study.
    Carapella CM, Paggi MG, Calvosa F, Cattani F, Jandolo B, Mastrostefano R, Raus L, Riccio A.
    J Neurosurg Sci; 1990 Jul 01; 34(3-4):261-4. PubMed ID: 2098504
    [Abstract] [Full Text] [Related]

  • 16. The role of mitochondrial hexokinase in neoplastic phenotype and its sensitivity to lonidamine.
    Paggi MG, Fanciulli M, Perrotti N, Floridi A, Zeuli M, Silvestrini B, Caputo A.
    Ann N Y Acad Sci; 1988 Jul 01; 551():358-60. PubMed ID: 3245672
    [No Abstract] [Full Text] [Related]

  • 17. The potential role of lonidamine (LND) in the treatment of malignant glioma. Phase II study.
    Carapella CM, Paggi MG, Cattani F, Ciottoli GB, Floridi A, Iandolo B, Raus L, Riccio A, Caputo A.
    J Neurooncol; 1989 May 01; 7(1):103-8. PubMed ID: 2666593
    [Abstract] [Full Text] [Related]

  • 18. Lonidamine-induced, pH dependent inhibition of cellular oxygen utilization.
    Stryker JA, Gerweck LE.
    Radiat Res; 1988 Feb 01; 113(2):356-61. PubMed ID: 3340739
    [Abstract] [Full Text] [Related]

  • 19. Lonidamine in malignant brain tumors.
    Schiffer D, Sales S, Soffietti R.
    Semin Oncol; 1991 Apr 01; 18(2 Suppl 4):38-41. PubMed ID: 2031197
    [Abstract] [Full Text] [Related]

  • 20. Morphological effects of lonidamine on two human-tumor cell culture lines.
    Szekely JG, Lobreau AU, Delaney S, Raaphorst GP, Feeley M.
    Scanning Microsc; 1989 Jun 01; 3(2):681-91; discussion 691-3. PubMed ID: 2814409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.